ARVINDA PADMANABHAN: Open Payments
NPI 1629280656 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,537 in 122 payments from 33 companies in 2025. Trend: 2023 $1,175 · 2024 $2,207 · 2025 $3,537
Food & beverage: $2,486Travel & lodging: $958Education: $93
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 18 | $1,473 |
| PFIZER INC. | 17 | $272 |
| Janssen Biotech, Inc. | 12 | $209 |
| Astellas Pharma US Inc | 11 | $161 |
| ABBVIE INC. | 5 | $120 |
| SEAGEN INC. | 1 | $93 |
| Daiichi Sankyo Inc. | 4 | $88 |
| Eisai Inc. | 4 | $86 |
| Gilead Sciences, Inc. | 4 | $82 |
| Genentech USA, Inc. | 4 | $77 |
Products named: KEYTRUDA, Xtandi, IBRANCE, VENCLEXTA, Lenvima, Trodelvy, ELREXFIO, Vyloy.
Industry payments across KY — which companies pay providers there.
